33 new stories
1. Leading HBCU showcases its top inventors and researchers - US Black Engineer
Domain: blackengineer.com... patents, one co-patent, and six pending patents. Four of Magee's patents are licensed to UVC CDE Technology LLC. S. Satayanryan Dev, the ...
2. Appeals court upholds USPTO ruling, says Zap-X did not infringe on Elekta's patents
Domain: dotmed.comAppeals court upholds USPTO ruling, says Zap-X did not infringe on Elekta's patents ... The U.S. Federal Court of Appeals has dismissed Elekta's patent ...
3. Khalifa University implements 30 initiatives to support Abu Dhabi's sustainability efforts
Domain: wam.aeKhalifa University has recently listed 54 patents in advanced materials and manufacturing, clean and renewable energy, environment, hydrocarbon ...
4. Time to pause - The Parliament Magazine
Domain: theparliamentmagazine.euEven before its publication, the standard essential patents (SEP) regulation divided stakeholders in Europe's intellectual property ecosystem. But ...
5. US Supreme Court rebuffs CareDx patent lawsuit over organ-rejection tests - Reuters
Domain: reuters.com... patents related to its AlloSure blood test for monitoring kidney transplants. The patents, which CareDx licenses from Stanford University, cover ...
6. Kavanaugh Signals Openness to Revisiting Patent Eligibility Framework as Supreme Court ...
Domain: patentlyo.comThis leaves in place a Federal Circuit ruling that invalidated CareDx's patents on its method for detecting organ transplant rejection. The patents ...
7. Shenzhen Targetrx Biotechnology patents new BTK and BTK mutant inhibitors | BioWorld
Domain: bioworld.comShenzhen Targetrx Biotechnology patents new BTK and BTK mutant inhibitors. Oct. 2, 2023. No Comments. Shenzhen Targetrx Biotechnology Co. Ltd. has ...
8. MarkIt to Market® - September 2023: How Design Patents Can Complement Brands ... - JD Supra
Domain: jdsupra.comHowever, owners may not appreciate another type of intellectual property right that can complement their trademark portfolios: design patents. Below ...
9. Nobel Prize for mRNA Researchers Shows Power of Public Funding for Vaccines, Campaigners Say
Domain: commondreams.orgKarikó and Weissman patented their findings in 2006 and later licensed the patents to Moderna and BioNTech, Pfizer's coronavirus vaccine partner.
10. US: Intellectual property protections for new crop varieties have increased - Hortidaily
Domain: hortidaily.comFrom 2016 to 2020, a total of 5,137 plant patents, 5,010 utility patents, and 2,028 Plant Variety Protection certificates were issued for new crop ...
11. A visionary with heart - USPTO
Domain: uspto.govDuring his career, NASA scientist Robert Bryant has been awarded more than 30 patents, developed technology for life-saving equipment, ...
12. Nextleaf Solutions announces leadership changes, adds new CFO and Board Member
Domain: investing.comIt holds 15 U.S. patents, and 75 patents globally, on cannabinoid processing including extraction, distillation, and acetylation. Nextleaf ...
13. Pharmalittle: Court allows Medicare drug price negotiation to proceed - STAT News
Domain: statnews.comPharmalittle: Court allows Medicare drug price negotiation to proceed; J&J will not enforce patents on key TB drug ... Good morning, everyone, and ...
14. Johnson & Johnson Confirms Intent Not to Enforce Patents for SIRTURO for the Treatment of ...
Domain: marketscreener.comNew Brunswick - Johnson & Johnson (the Company ) (NYSE: JNJ) today confirmed its intent not to enforce patents it owns and controls for SIRTURO ...
15. PayPal Files Patents Related to NFTs | News - ihodl.com
Domain: ihodl.comPayPal Files Patents Related to NFTs. José Rodríguez · Editor. Payments giant PayPal has just filed four patent applications to ...
16. LG is dropping ATSC 3.0 from its TVs Next Year - Mix 93.3
Domain: mix93.com | Companies: LGAccording to The Verge, LG's decision follows its patent fight loss with a company that holds multiple ATSC 3.0 patents. LG “strongly” urged the FCC ...
17. PrimeC, potential ALS therapy, earns patents in Europe, Japan, Israel | ALS News Today
Domain: alsnewstoday.comNeuroSense received patents covering the use of PrimeC in Europe, Japan, and Israel; topline data from the Phase 2 trial are expected soon.
18. Global Craniomaxillofacial Implants Market Report - GlobeNewswire
Domain: globenewswire.comGlobal Craniomaxillofacial Implants Market Report 2023-2031: Patents, Grants, Clinical Trials Analysis, Funding and Investments, Partnerships, and ...
19. Applied Optoelectronics Amends Patent Infringement Lawsuit - GlobeNewswire
Domain: globenewswire.com... patents. “Patents are extremely important to AOI's optical transceiver business. Therefore, AOI is taking, and will continue to take the steps ...
20. Cellectar Biosciences Expands Global Intellectual Property Portfolio with Four Patent Grants
Domain: investorsobserver.com | Companies: Target"The issuance of these important patents underscores our platform and thereby our compounds' unique ability to target not only the primary tumor but ...
21. Case: Patents/Anticipation (P.T.A.B.) - Bloomberg Law News
Domain: news.bloomberglaw.comCase: Patents/Anticipation (P.T.A.B.) ... According to the board, the challenged claims are anticipated by prior art directed to crystalline forms and ...
22. US Supreme Court Declines to Hear CareDx Organ Transplant Patent Infringement Case
Domain: genomeweb.com... patents related to cell-free DNA analysis for noninvasive monitoring of organ transplant rejection. CareDx had announced earlier that it was ...
23. Double Trouble for Double Patenting or When Does My Patent Expire?
Domain: manatt.comIn In re Cellect, the Federal Circuit explained that ODP is considered after any PTA is applied, which could cause patents with terms that have ...
24. Cellectar Biosciences Shares Rise 10% After Being Granted Four Patents - MarketWatch
Domain: marketwatch.comBy Chris Wack Cellectar Biosciences shares were up 10% to $2.91 on Monday after the company said it secured four patents across Europe, ...
25. Inflation Reduction Act May Curb Patent Practices That Forestall Market Entry Of Biosimilars
Domain: forbes.comFour blockbuster drugs—Humira, Avastin, Rituxan and Lantus—generated 56% of their overall revenue after expiration of their initial patents. Among ...
26. IP licence agreements: an overview - Inventa
Domain: inventa.comProtect your Intellectual Property with Inventa - Trademarks, Patents, Copyright and Domains. Learn More.
27. Student-faculty team of inventors devises tools to address orthopedic challenges
Domain: news.arizona.edu... for surgical hardware removal. The team worked with Tech Launch Arizona to file patents and license its intellectual property.
28. Johnson & Johnson says it won't enforce secondary patents on tuberculosis med Sirturo
Domain: fiercepharma.com... patents on the treatment in 134 countries. Now, generic makers in low-and middle-income countries can sell their own versions of Sirturo if they ...
29. Samsung is set to announce a new Cloud Gaming Service for Galaxy Devices at their ...
Domain: patentlyapple.com | Companies: Apple, SamsungContinuation Patents (133) · 2. Granted Patents (1858) · 3. Patently Legal (811) · 4. Trademark, Design Patents (854) · 5. Apple News (3498) · 5.
30. Microsoft Withstands SAIC's Night Vision Goggle Patent Challenge - Bloomberg Law News
Domain: news.bloomberglaw.com | Companies: Microsoftprovided night vision goggle systems to the government that infringed its patents. Microsoft won summary judgment of non-infringement, a US Court of ...
31. US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic | Reuters
Domain: reuters.comA U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its ...
32. Olaplex Launches Oladupé Marketing Campaign | HAPPI
Domain: happi.comBut with its patents ... While the Oladupe product's label looked very similar to Olaplex, it was clearly marked Oladupe "No. 160" (as an homage to ...
33. Johnson & Johnson drops secondary patents for bedaquiline - CIDRAP
Domain: cidrap.umn.eduDrug maker Johnson & Johnson (J&J) announced last week that it will not enforce secondary patents on a drug that's considered the backbone of ...